Literature DB >> 3519770

Full reconstitution of the immune deficiency in scid mice with normal stem cells requires low-dose irradiation of the recipients.

G M Fulop, R A Phillips.   

Abstract

Mice homozygous for an autosomal recessive mutation for the scid gene exhibit a defect that specifically impairs lymphoid differentiation but not myelopoiesis. Such mice can be cured of their lymphoid deficiency by grafts with normal bone marrow, although full reconstitution of lymphoid function is seldom obtained. Long-term bone marrow cultures (LTBMC) are devoid of all mature B and pre-B cells but contain lymphoid stem cells. We therefore reconstituted scid mice with LTBMC cells to study the kinetics of B lymphocyte reconstitution in normal and irradiated (4 Gy) scid recipients and in irradiated (9.5 Gy) co-isogenic C.B-17 mice. Detectable colony-forming B cells rapidly increased in the spleen and bone marrow of irradiated C.B-17 and irradiated scid recipients, reaching normal levels between 4 and 6 wk post-grafting. Unirradiated scid recipients showed limited reconstitution in spleen and very poor reconstitution in bone marrow. Unirradiated scid recipients also had relatively few surface Ig+ cells in spleen or bone marrow, whereas both groups of irradiated recipients had normal numbers between 4 and 6 wk post-reconstitution. Normal levels of cytotoxic T cell activity by 8 wk after reconstitution were observed only in the irradiated C.B-17 and irradiated scid recipients. Analysis of mice reconstituted with cells from LTBMC indicates that these cultures contain lymphoid stem cells with significant proliferative and self-renewal potential, and that full reconstitution of lymphoid function requires prior irradiation of the scid recipient.

Entities:  

Mesh:

Year:  1986        PMID: 3519770

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Immature B-cell progenitors survive oncogenic stress and efficiently initiate Ph+ B-acute lymphoblastic leukemia.

Authors:  Robert A J Signer; Encarnacion Montecino-Rodriguez; Owen N Witte; Kenneth Dorshkind
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

3.  Reconstitution of SCID mice with haemopoietic precursors: a detailed analysis of gamma delta T-cell reconstitution.

Authors:  K A Kelly; R O'Brien; W Born
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

4.  Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative function.

Authors:  P A Scherle; K Dorshkind; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  Rapid restoration of B-cell function in XID mice by intravenous transfer of peritoneal cavity B cells.

Authors:  L Prior; S Pierson; R T Woodland; J Riggs
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 6.  The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases.

Authors:  A O Vladutiu
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

Review 7.  In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.

Authors:  T S Barry; B F Haynes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

8.  Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.

Authors:  M A Duchosal; S A Eming; P J McConahey; F J Dixon
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

Review 9.  Potential of the scid mouse as a host for human tumors.

Authors:  B M Mueller; R A Reisfeld
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

10.  Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies.

Authors:  A Durandy; N Brousse; F Rozenberg; G De Saint Basile; A M Fischer; A Fischer
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.